This content is not available in your region

U.S. FDA advisers vote in favor of booster for J&J COVID-19 vaccine

Access to the comments Comments
By Reuters
U.S. FDA advisers vote in favor of booster for J&J COVID-19 vaccine
U.S. FDA advisers vote in favor of booster for J&J COVID-19 vaccine   -   Copyright  Thomson Reuters 2021

– A panel of advisers to the U.S. Food and Drug Administration on Friday voted to recommend the authorization of a second dose of Johnson & Johnson’s COVID-19 vaccine for people aged 18 and older at least two months after the first dose.